Acesion Pharma Strengthens Clinical Team with Key Appointments
Acesion Pharma, a Danish pharmaceutical company developing novel treatments for atrial fibrillation (AF), the most common cardiac...
top of page
- Mar 12, 2019
- 2 min
Acesion Pharma receives 5M DKK from Innovation Fund Denmark to support human Proof-of-Concept study
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
134 views
- Nov 5, 2018
- 2 min
Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation
Acesion Pharma (“Acesion” or the Company), a Danish biotech company developing novel treatments for atrial fibrillation (AF), the most...
227 views
LATEST NEWS
bottom of page